| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kawde AN et al. | Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. | 2014 | Acta Chim Slov | pmid:25125124 |
| Evans SE et al. | The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. | 2014 | PLoS ONE | pmid:24595451 |
| Dechert-Schmitt AM et al. | Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. | 2014 | Nat Prod Rep | pmid:24514754 |
| Kumar S et al. | Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. | 2013 | Bioorg. Med. Chem. Lett. | pmid:23474387 |
| Singh R et al. | No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. | 2013 | AIDS | pmid:23014518 |
| Rosette C et al. | Anti-inflammatory and immunomodulatory activities of rifamycin SV. | 2013 | Int. J. Antimicrob. Agents | pmid:23756321 |
| Falkinham JO et al. | Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. | 2012 | Tuberculosis (Edinb) | pmid:22209468 |
| Calatayud M et al. | In vitro study of transporters involved in intestinal absorption of inorganic arsenic. | 2012 | Chem. Res. Toxicol. | pmid:22214486 |
| Farrell DJ et al. | In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile. | 2011 | Antimicrob. Agents Chemother. | pmid:21149623 |
| Yuan H et al. | Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. | 2011 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:21986914 |